Objective:To explore the correlation between conventional ultrasound and contrast-enhanced ultrasound features and invasive histological features of T 1a clear cell renal cell carcinoma (ccRCC). Methods:A retrospective case series study was conducted. Sixty-seven T 1a ccRCC patients who were admitted to Shanxi Province Cancer Hospital from May 2018 to August 2023 were selected. According to the World Health Organization (WHO)/International Society of Urology and Pathology (ISUP) renal tumor grading system, the patients were divided into the low-grade group (WHO/ISUP grades 1-2, 53 cases) and the high-grade group (WHO/ISUP grades 3-4, 14 cases). The conventional ultrasound and contrast-enhanced ultrasound characteristics of two groups of patients were compared. Multivariate logistic regression model was used to analyze the independent factors of conventional ultrasound and contrast-enhanced ultrasound related to T 1a ccRCC with WHO/ISUP high grade. Results:There were no statistically significant differences in clinical characteristics between the two groups of patients (all P > 0.05). In conventional ultrasound examination, the proportion of patients with tumor exophytic rate <50% in the high-grade group was higher than that in the low-grade group [64.3% (9/14) vs. 34.0% (18/53)], and the difference was statistically significant ( χ2 = 4.23, P = 0.040); there were no statistically significant differences in the distribution of patients with different tumor maximum diameter, laterality, polarity, depth, echo, boundary, and shape between the two groups (all P > 0.05). In contrast-enhanced ultrasound examination, the proportion of patients lack of pseudocapsule sign in the high-grade group was higher than that in the low-grade group [57.1% (8/14) vs. 24.5% (13/53)], and the difference was statistically significant ( χ2 = 4.06, P = 0.044); there were no statistically significant differences in the distribution of patients with different perfusion mode, enhancement degree, enhancement uniformity, and regression mode between the two groups (all P > 0.05). Multivariate logistic regression analysis showed that the conventional ultrasound tumor exophytic rate < 50% (compared to exophytic rate ≥ 50%, OR = 3.732, 95% CI: 1.019-13.664, P = 0.047) and the absence of pseudocapsule sign (compared to the presence of pseudocapsule sign, OR = 4.357, 95% CI: 1.201-15.804, P = 0.025) on contrast-enhanced ultrasound were independent risk factors for high-grade T 1a ccRCC. Conclusions:T 1a ccRCC with the exophytic rate <50% and absence of pseudocapsule sign may have invasive histological features.

Objective:To explore the correlation between conventional ultrasound and contrast-enhanced ultrasound features and invasive histological features of T 1a clear cell renal cell carcinoma (ccRCC). Methods:A retrospective case series study was conducted. Sixty-seven T 1a ccRCC patients who were admitted to Shanxi Province Cancer Hospital from May 2018 to August 2023 were selected. According to the World Health Organization (WHO)/International Society of Urology and Pathology (ISUP) renal tumor grading system, the patients were divided into the low-grade group (WHO/ISUP grades 1-2, 53 cases) and the high-grade group (WHO/ISUP grades 3-4, 14 cases). The conventional ultrasound and contrast-enhanced ultrasound characteristics of two groups of patients were compared. Multivariate logistic regression model was used to analyze the independent factors of conventional ultrasound and contrast-enhanced ultrasound related to T 1a ccRCC with WHO/ISUP high grade. Results:There were no statistically significant differences in clinical characteristics between the two groups of patients (all P > 0.05). In conventional ultrasound examination, the proportion of patients with tumor exophytic rate <50% in the high-grade group was higher than that in the low-grade group [64.3% (9/14) vs. 34.0% (18/53)], and the difference was statistically significant ( χ2 = 4.23, P = 0.040); there were no statistically significant differences in the distribution of patients with different tumor maximum diameter, laterality, polarity, depth, echo, boundary, and shape between the two groups (all P > 0.05). In contrast-enhanced ultrasound examination, the proportion of patients lack of pseudocapsule sign in the high-grade group was higher than that in the low-grade group [57.1% (8/14) vs. 24.5% (13/53)], and the difference was statistically significant ( χ2 = 4.06, P = 0.044); there were no statistically significant differences in the distribution of patients with different perfusion mode, enhancement degree, enhancement uniformity, and regression mode between the two groups (all P > 0.05). Multivariate logistic regression analysis showed that the conventional ultrasound tumor exophytic rate < 50% (compared to exophytic rate ≥ 50%, OR = 3.732, 95% CI: 1.019-13.664, P = 0.047) and the absence of pseudocapsule sign (compared to the presence of pseudocapsule sign, OR = 4.357, 95% CI: 1.201-15.804, P = 0.025) on contrast-enhanced ultrasound were independent risk factors for high-grade T 1a ccRCC. Conclusions:T 1a ccRCC with the exophytic rate <50% and absence of pseudocapsule sign may have invasive histological features.

Objective:To explore the diagnostic value of ultrasound combined with tumor markers carcinoembryonic antigen (CEA) and carbohydrate antigen 199 (CA199) for peritoneal metastasis of gastrointestinal adenocarcinoma.Methods:A retrospective case series study was conducted. A total of 140 patients with gastrointestinal adenocarcinoma who were admitted to Shanxi Province Cancer Hospital from August 2021 to January 2023 were collected. Preoperative diagnosis of peritoneal metastasis was performed using tumor markers CEA and CA199 (tumor marker method) and ultrasound combined with CEA and CA199 (combined method). Using postoperative pathological results as the gold standard, the detection rate and diagnostic efficacy of the two methods for peritoneal metastasis in patients were compared.Results:Among 140 patients, there were 78 males and 62 females; the age was (59±5) years old; there were 40 cases of gastric cancer and 100 cases of colorectal cancer; pathological staging: 4 cases in stage Ⅰ, 36 cases in stage Ⅱ, 52 cases in stage Ⅲ, and 48 cases in stage Ⅳ. All patients underwent radical resection surgery, and postoperative pathological results showed that 32 cases (22.86%) had peritoneal metastasis. The detection rate of combined method for peritoneal metastasis of gastrointestinal adenocarcinoma was higher than that of tumor marker method [96.88% (31/32) vs. 78.13% (25/32)], but the difference was not statistically significant ( χ2 = 5.14, P = 0.059). The sensitivity of tumor marker method for diagnosing peritoneal metastasis of gastrointestinal adenocarcinoma was 64.00%, the specificity was 86.09%, the positive predictive value was 50.00%, the negative predictive value was 91.67%, the Kappa value was 0.379, and the area under the curve (AUC) was 0.793. The sensitivity of combined method for diagnosing peritoneal metastasis of gastrointestinal adenocarcinoma was 77.42%, the specificity was 92.66%, the positive predictive value was 75.00%, the negative predictive value was 93.52%, the Kappa value was 0.905, and the AUC was 0.985. The sensitivity and positive predictive value of combined method for diagnosing peritoneal metastasis of gastrointestinal adenocarcinoma were higher than those of tumor marker method, and the differences were statistically significant ( χ2 values were 4.06 and 13.33, both P < 0.05). Conclusions:Ultrasound combined with serum tumor markers CEA and CA199 has high diagnostic value for peritoneal metastasis of gastrointestinal adenocarcinoma.

Objective:To explore the diagnostic value of ultrasound combined with tumor markers carcinoembryonic antigen (CEA) and carbohydrate antigen 199 (CA199) for peritoneal metastasis of gastrointestinal adenocarcinoma.Methods:A retrospective case series study was conducted. A total of 140 patients with gastrointestinal adenocarcinoma who were admitted to Shanxi Province Cancer Hospital from August 2021 to January 2023 were collected. Preoperative diagnosis of peritoneal metastasis was performed using tumor markers CEA and CA199 (tumor marker method) and ultrasound combined with CEA and CA199 (combined method). Using postoperative pathological results as the gold standard, the detection rate and diagnostic efficacy of the two methods for peritoneal metastasis in patients were compared.Results:Among 140 patients, there were 78 males and 62 females; the age was (59±5) years old; there were 40 cases of gastric cancer and 100 cases of colorectal cancer; pathological staging: 4 cases in stage Ⅰ, 36 cases in stage Ⅱ, 52 cases in stage Ⅲ, and 48 cases in stage Ⅳ. All patients underwent radical resection surgery, and postoperative pathological results showed that 32 cases (22.86%) had peritoneal metastasis. The detection rate of combined method for peritoneal metastasis of gastrointestinal adenocarcinoma was higher than that of tumor marker method [96.88% (31/32) vs. 78.13% (25/32)], but the difference was not statistically significant ( χ2 = 5.14, P = 0.059). The sensitivity of tumor marker method for diagnosing peritoneal metastasis of gastrointestinal adenocarcinoma was 64.00%, the specificity was 86.09%, the positive predictive value was 50.00%, the negative predictive value was 91.67%, the Kappa value was 0.379, and the area under the curve (AUC) was 0.793. The sensitivity of combined method for diagnosing peritoneal metastasis of gastrointestinal adenocarcinoma was 77.42%, the specificity was 92.66%, the positive predictive value was 75.00%, the negative predictive value was 93.52%, the Kappa value was 0.905, and the AUC was 0.985. The sensitivity and positive predictive value of combined method for diagnosing peritoneal metastasis of gastrointestinal adenocarcinoma were higher than those of tumor marker method, and the differences were statistically significant ( χ2 values were 4.06 and 13.33, both P < 0.05). Conclusions:Ultrasound combined with serum tumor markers CEA and CA199 has high diagnostic value for peritoneal metastasis of gastrointestinal adenocarcinoma.

【Objective】 To conduct the laboratory quality assessment between 12 blood stations in Hebei province, analyze the results and explore the accuracy and comparability of testing, so as to improve the level of testing ability and quality management. 【Methods】 With reference to the external quality assessment rules of National Center for Clinical Laboratories and combined with the instructions of quality assessment samples, daily testing process of the laboratories were assessed. The quality indicators include blood cell count (WBC, RBC, Hb, HCT, MCV, MCH, MCHC and PLT), biochemical items (TP) and coagulation parameters (FIB and FⅧ). 【Results】 There are still problems in laboratories in terms of personnel operation, instrument maintenance and the impact of different reagent batches, especially in biochemical items and coagulation parameters. The pass rate of biochemical items was the lowest, only 72.75%, and that of blood cell count was the highest, reaching 98.75%. 【Conclusion】 With the progress of the project, the quality monitoring level of daily blood sampling tests in the quality control laboratory of each blood station has been improved. However, it is still necessary for each laboratory to improve the testing ability and quality management to a higher level in Hebei.

Objective:To investigate the influencing factors of ultrasonic missed diagnosis of kidney neoplasm.Methods:The clinical data of 2 033 patients pathologically diagnosed with kidney neoplasm after operation and with complete medical record in Shanxi Province Cancer Hospital from January 2013 to October 2021 were retrospectively analyzed. Preoperative ultrasound diagnosis, clinical data, CT/magnetic resonance imaging (MRI) were analyzed, and ultrasound missed diagnosis rate was calculated. Chi-square test and multivariate logistic regression were used to analyze the influencing factors of ultrasonic missed diagnosis of kidney neoplasm mainly based on the anatomic characteristics of neoplasm.Results:The ultrasonic missed diagnosis rate of kidney neoplasm was 1.87% (38/2 033), among which the ultrasonic missed diagnosis rate of renal parenchymal neoplasm was 1.33% (25/1 874) and the ultrasonic missed diagnosis rate of renal pelvis neoplasm was 8.18% (13/159). The results of multivariate logistic regression analysis showed that the patients' body mass index (BMI) ≥ 24 kg/m 2 ( OR = 2.805, 95% CI 1.030-7.641), the small lesion ( OR = 0.425, 95% CI 0.293-0.617), the lesion located on the left kidney ( OR = 0.307, 95% CI 0.113-0.834), the lesion located on the body ( OR = 0.344, 95% CI 0.124-0.956 compared to lesions in the upper pole of the kidney; OR = 0.239, 95% CI 0.069-0.834 compared to lesions in the lower pole of the kidney) and the lesion located on the dorsal side ( OR = 0.409, 95% CI 0.172-0.970) were independent influencing factors for ultrasound missed diagnosis of renal parenchymal neoplasms (all P < 0.05). Patients with BMI ≥ 24 kg/m 2 ( OR = 10.464, 95% CI 1.042-105.087), concurrent ureteral or (and) bladder urothelial carcinoma ( OR = 32.937, 95% CI 4.017-270.063), and small lesion size ( OR = 0.216, 95% CI 0.081-0.577) were independent influencing factors for ultrasound missed diagnosis of renal pelvis neoplasms (all P < 0.05). Conclusions:Obesity, small focus, focus on the left kidney, focus on the body, and focus on the back may be the main reasons for ultrasonic missed diagnosis of renal parenchymal neoplasms. Obesity, concurrent ureteral or/and bladder urothelial carcinoma and small lesions may be the main reasons for ultrasonic missed diagnosis of renal pelvis neoplasms.

Objective:To observe the clinical efficacy and safety of decitabine combined with low-dose cytarabine in treatment of high-risk myelodysplastic syndrome.Methods:The data of 47 newly treated MDS patients who had high-risk or above scores according to revised international prognostic scoring system (IPSS-R) in the Affiliated Hospital of Qingdao University from January 2016 to September 2018 were retrospectively analyzed. The patients were divided into decitabine combined with low-dose cytarabine group (15 cases) and decitabine group (32 cases). The clinical efficacy and adverse reactions in two groups were compared.Results:After 4 courses of treatment, the bone marrow remission rate, partial remission rate and hematologic remission rate was 20.0% (3/15), 6.7% (1/15), and 13.3% (2/15), respectively in decitabine combined with low-dose cytarabine group, and was 28.1% (9/32), 3.1% (1/32), and 9.4% (3/32), respectively in decitabine group, and there were no statistically differences of both groups (both P > 0.05). The overall response rate in decitabine combined with low-dose cytarabine group was higher than that in decitabine group [93.3% (14/15) vs. 62.5% (20/32), P = 0.037], and the complete remission rate in decitabine combined with low-dose cytarabine group was higher than that in decitabine group [53.3% (8/15) vs. 21.9% (7/32), P = 0.046]. The 1-year overall survival (OS) rate of decitabine combined with low-dose cytarabine group was 86%; and the median OS time of decitabine combined with low-dose cytarabine group was 24 months (95% CI 15.5-32.5 months), which was higher than that of decitabine group (20 months), but there was no statistically significant difference ( χ2 = 0.058, P = 0.810). The incidence of grade Ⅲ-Ⅳ bone marrow suppression and infection in decitabine combined with low-dose cytarabine group was higher than that in decitabine group, but there were no statistically significant differences of both groups (both P > 0.05). Grade Ⅲ-Ⅳ bone marrow suppression and infection were commonly found within the first 2 courses of treatment in decitabine combined with low-dose cytarabine group, and the adverse reactions gradually decreased in the subsequent treatment. Conclusions:Decitabine combined with low-dose cytarabine can achieve better remission rate and prolong survival time for MDS patients with high-risk and above. There is no significant increase in the incidence of grade Ⅲ-Ⅳ bone marrow suppression and infection. For high-risk MDS patients who are not suitable or unable to receive hematopoietic stem cell transplantation, it can be the preferred option.

The "three eye-needling" technique is one of the important component of's three needling therapy, mainly used for the treatment of eye disorders such as optic atrophy, macular pigment degeneration, myopia, hyperopia, strabismus, amblyopia, diplopia, glaucoma, cataract, etc. In the paper,'s "three eye-needling" technique is explored, including the keys of manipulation, operation procedure and basic skills. This technique is particularly for "mind regulation", focusing on tranquilizing, observing and concentrating the mind. The precise selection of point is the basic requirement, the technique for fixing, pressing and pricking are the most important link. The needle insertion with one hand is adopted with gentle rotation manipulation. Mind regulation, point selection and specific operation are coordinated with each other to bring the function of "three eye-needling" technique into play and achieve better therapeutic effects.

Primary hepatic lymphoma (PHL) is an extremely rare disease without any unified diagnostic criterion.The symptoms are usually nonspecific.Liver biopsy remains the most valuable tool for diagnosis of PHL.The predominant histology of PHL is diffuse large B-cell lymphoma.The therapeutic modalities are variable,including surgery,chemotherapy,radiotherapy,or combination of the various processes.This article described a 33-year-old man with diffuse large B-cell PHL who was treated at the Affiliated Cancer Hospital of Shanxi Medical Univeitity Blood Disease Diagnosis and Treatment Center in February 2014.The patient benefited from eight-cycle chemotherapy.At present,the patient is disease-free and undergoes regular follow-up.

Objective To evaluate the ultrasonographic features of enlarged central lymph nodes in thyroid microcarcinoma and its clinical significance.Methods The data of 422 cases of thyroid microcarcinoma in Shanxi Medical University Affiliated Tumor Hospital from January 2014 to December 2014 was investigated retrospectively.For the enlarged central lymph nodes,the results of ultrasonography,intraoperative detection and surgical pathology were compared,and the ultrasound characteristics of enlarged lymph nodes were assessed.Results In 422 cases of thyroid microcarcinoma,128 cases of central compartment lymphadenopathy were identified,including 276 nodes detected by preoperative ultrasound.The ultrasonic characteristics of central lymph nodes included hypo-echoic (98.6％,272/276),L/T ≥ 2 (63.8％,176/276),absence of echogenic hilus (72.1％,199/276),poor blood supply (91.7％,253/276).Surgery detected 978 paratracheal lymph nodes,and 522 nodules were ≤ 5.0 mm in diameter (53.4％).Among 422 patients,100 cases with paratracheal lymph nodes were confirmed by pathology (23.7％).Preoperative ultrasound undetected pretracheal and prelaryngeal lymph nodes,and surgery detected 51 nodes,including 30 nodules ≤ 5.0 mm in diameter (58.8％) and 5 nodules ＞ 10.0 mm in diameter (9.8％),of whom 7 cases with pretracheal and prelaryngeal lymph nodes were identified by pathology.Conclusions Preoperative ultrasound was prone to undetected,which may be involved with the deep location,the smaller diameter and complicated anatomy.The present findings emphasize that a negative US does not obviate the need for careful exploration of the central compartment to minimize the risk of persistent or recurrent local disease.The sonographer should be familiar with the status of central lymph node metastasis and ultrasonic features.The sonographer also should expand the area of the initiative while detect the central compartment lymphadenopathy,which is important guiding for surgical removal of thyroid cancer and lymph node metastasis.